Paper32061310
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.
Shahbandi A and 2 others. Trends Cancer, 2020. Cited by 162 papers, by iCite.
Cite this record
ConductScience Library. TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines. Papers, record 32061310. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32061310
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Breast Neoplasms | Major topic |
| Mastectomy | Major topic |
| Neoadjuvant Therapy | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Animals | |
| Breast | |
| Chemotherapy, Adjuvant | |
| Clinical Decision-Making | |
| DNA Mutational Analysis | |
| Disease Models, Animal | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Mice | |
| Mutation | |
| Patient Selection | |
| Practice Guidelines as Topic |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TL1 TR003106 | NCATS NIH HHS | United States | TL1TR003106 | PubMed and NIH |
Source NIH RePORTER
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9649144 | Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9649144 | PubMed |
| 2 | 21556366 | Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel. | PLoS One | 2011 | https://conductscience.org/library/papers/21556366 | PubMed |
| 3 | 23849169 | Ionizing-radiation induced DNA double-strand breaks: a direct and indirect lighting up. | Radiother Oncol | 2013 | https://conductscience.org/library/papers/23849169 | PubMed |
| 4 | 10719728 | A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10719728 | PubMed |
| 5 | 2056391 | p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. | J Pathol | 1991 | https://conductscience.org/library/papers/2056391 | PubMed |
| 6 | 7882357 | Racial disparity in the association of p53 gene alterations with breast cancer survival. | Cancer Res | 1995 | https://conductscience.org/library/papers/7882357 | PubMed |
| 7 | 20549698 | p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines. | Int J Cancer | 2011 | https://conductscience.org/library/papers/20549698 | PubMed |
| 8 | 19806450 | Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy. | Breast Cancer Res Treat | 2010 | https://conductscience.org/library/papers/19806450 | PubMed |
| 9 | 20228131 | Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers. | Oncologist | 2010 | https://conductscience.org/library/papers/20228131 | PubMed |
| 10 | 24909504 | TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy. | Acta Oncol | 2014 | https://conductscience.org/library/papers/24909504 | PubMed |
| 11 | 19097774 | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19097774 | PubMed |
| 12 | 30605222 | Association Between Reimbursement Incentives and Physician Practice in Oncology: A Systematic Review. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/30605222 | PubMed |
| 13 | 11912168 | DNA damage is able to induce senescence in tumor cells in vitro and in vivo. | Cancer Res | 2002 | https://conductscience.org/library/papers/11912168 | PubMed |
| 14 | 12563311 | The role of p53 in determining sensitivity to radiotherapy. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12563311 | PubMed |
| 15 | 8259215 | A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. | Nature | 1993 | https://conductscience.org/library/papers/8259215 | PubMed |
| 16 | 28427202 | Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes. | Oncotarget | 2017 | https://conductscience.org/library/papers/28427202 | PubMed |
| 17 | 23873310 | The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis. | Sci Rep | 2013 | https://conductscience.org/library/papers/23873310 | PubMed |
| 18 | 11289122 | Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. | Cancer Res | 2001 | https://conductscience.org/library/papers/11289122 | PubMed |
| 19 | 16968874 | Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy. | Ann Oncol | 2006 | https://conductscience.org/library/papers/16968874 | PubMed |
| 20 | 22198468 | Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22198468 | PubMed |
Cited by132
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42853938 | Targeting SUV39H2 exon skipping reverses resistance to CDK4/6 inhibitors via transcriptional activation of p21. | Sci Adv | 2026 | https://conductscience.org/library/papers/42853938 | PubMed |
| 42701099 | Covalent Targeting and Thermostabilization of Oncogenic R280K and R273H Mutants p53 by Small Molecule RVJB59. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42701099 | PubMed |
| 42630554 | Clinical outcomes and genomic landscape of anti-HER2 antibody-drug conjugates in HER2-positive and HER2-low metastatic breast cancer. | Ther Adv Med Oncol | 2026 | https://conductscience.org/library/papers/42630554 | PubMed |
| 42467271 | Succinylation related gene signature enables risk stratification and prognostic modeling in breast cancer patients. | Amino Acids | 2026 | https://conductscience.org/library/papers/42467271 | PubMed |
| 42449678 | Naturally Occurring Feline Cancers in Comparative Oncology: Translational Insights from Oral Squamous Cell Carcinoma and Mammary Carcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449678 | PubMed |
| 42352496 | Genomic Profiling of Breast Cancer in an Ecuadorian Cohort Reveals Clinically Relevant Variants and Ancestry-Related Interpretation Challenges. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42352496 | PubMed |
| 42325535 | Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-need. | J Liq Biopsy | 2026 | https://conductscience.org/library/papers/42325535 | PubMed |
| 42316306 | Large-scale transcriptomic data mining using explainable XGBoost and SHAP reveals shared biomarkers and molecular mechanisms between type-2 diabetes and triple-negative breast cancer for drug repurposing. | BioData Min | 2026 | https://conductscience.org/library/papers/42316306 | PubMed |
| 42250175 | Integrating multi-omics and clinical management in breast cancer: a comprehensive review. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42250175 | PubMed |
| 42243652 | Multi-omics network inference with a Gaussian copula model. | BMC Bioinformatics | 2026 | https://conductscience.org/library/papers/42243652 | PubMed |
| 42196471 | Construction of a Lysine Lactylation- and DNA Damage Repair-Related Gene Signature to Predict the Prognosis and Drug Sensitivity of Breast Cancer Patients. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196471 | PubMed |
| 42146898 | DNA Methylation in Blood Samples from Malignant Mammary Tumors of Companion Dogs: A Pilot Study. | Comput Struct Biotechnol J | 2026 | https://conductscience.org/library/papers/42146898 | PubMed |
| 42101677 | Circadian clock control of breast cancer hallmarks: molecular mechanisms and therapeutic implications. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42101677 | PubMed |
| 42089753 | Benchmarking computational methods for multi-omics biomarker discovery in cancer. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42089753 | PubMed |
| 42081559 | Predicting protein cascade expression from H&E images. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42081559 | PubMed |
| 41939469 | Tamoxifen differentially modulates endometrial hyperplasia via wild-type and mutant p53 regulation of the ALKBH5-REG1A axis. | Front Oncol | 2026 | https://conductscience.org/library/papers/41939469 | PubMed |
| 41766646 | EpGAT: integrating epigenetics and 3D genome structure to predict alternative splicing and polyadenylation. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/41766646 | PubMed |
| 41764184 | Evaluation of non-canonical p53 functions in DNA replication and recombination for variant classification. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41764184 | PubMed |
| 41712721 | The oncogenome of the domestic cat. | Science | 2026 | https://conductscience.org/library/papers/41712721 | PubMed |
| 41646753 | Predicting Protein Cascade Expression from H&E Images. | medRxiv | 2026 | https://conductscience.org/library/papers/41646753 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BBC3 | 27113 | PubTator's text mining | https://conductscience.org/library/genes/27113 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PERP | 64065 | PubTator's text mining | https://conductscience.org/library/genes/64065 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| PMAIP1 | 5366 | PubTator's text mining | https://conductscience.org/library/genes/5366 | NCBI Gene |
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32061310
GET https://conductscience.org/api/papers/v1/32061310/references?page=2